AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimisil-MV 1.2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sansill Formulations

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimisil-MV 1.2 Tablet SR

Diabetac-Comb 1.2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by managing blood glucose levels. Diabetac-Comb 1.2mg ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continued use is crucial, even with well-managed blood sugar; abrupt cessation without medical consultation risks hyperglycemia, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is a component of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are crucial for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimisil-MV 1.2 Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimisil-MV 1.2 Tablet SR

Managing Type 2 diabetes

Major Benefits of Glimisil-MV 1.2 Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimisil-MV 1.2 Tablet SR on an empty stomach.

Common Side effects of Glimisil-MV 1.2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimisil-MV 1.2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisil-MV 1.2 SR Tablet on an empty stomach.

How Glimisil-MV 1.2 Tablet SR works:

One tablet of Glimisil-MV 1.2 SR contains a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisil-MV 1.2 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimisil-MV 1.2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glimisil-MV 1.2 SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Glimisil-MV 1.2 Tablet SR carries a high likelihood of risk for individuals with kidney impairment and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimisil-MV 1.2 SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimisil-MV 1.2 Tablet SR :

Should you forget a Glimisil-MV 1.2 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimisil-MV 1.2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimisil-MV 1.2 Tablet SR

Glimisil-MV 1.2 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-drug therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Glimisil-MV 1.2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infection.
Glimisil-MV 1.2 Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimisil-MV 1.2 Tablet SR with alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Glimisil-MV 1.2 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimisil-MV 1.2 Tablet SR
81
MRP 99
18% off